Quarterly report pursuant to sections 13 or 15(d)

Common Stock Equivalents

v2.4.0.8
Common Stock Equivalents
3 Months Ended
Mar. 31, 2014
Common Stock Equivalents [Abstract]  
COMMON STOCK EQUIVALENTS
11. 
COMMON STOCK EQUIVALENTS

COMPENSATION AND SERVICE WARRANTS AND OPTIONS

On November 30, 2012, the Company’s Board of Directors and a majority of the Company’s shareholders approved the Company’s 2012 Omnibus Incentive Plan (the “2012 Plan”). On January 11, 2013, the Board of Directors of the Company approved the Company’s 2013 Omnibus Incentive Plan (the “2013 Plan”, collectively “the Plans”). The 2013 Plan was approved by a majority of the Company’s shareholders on February 13, 2013. The Plans enable the Company to grant stock options, stock appreciation rights, restricted stock, restricted stock units, phantom stock and dividend equivalent rights to associates, directors, consultants, and advisors of the Company and its affiliates, and to improve the ability of the Company to attract, retain, and motivate individuals upon whom the Company’s sustained growth and financial success depend, by providing such persons with an opportunity to acquire or increase their proprietary interest in the Company.  Stock options granted under the Plan may be Non-Qualified Stock Options or Incentive Stock Options, within the meaning of Section 422(b) of the Internal Revenue Code of 1986, except that stock options granted to outside directors and any consultants or advisers providing services to the Company or an affiliate shall in all cases be Non-Qualified Stock Options. The Plans are to be administered by the Board, which shall have discretion over the awards and grants thereunder. The option price must be at least 100% of the fair market value on the date of grant and if issued to a 10% or greater shareholder must be 110% of the fair market value on the date of the grant. The aggregate maximum number of shares of Common Stock for which stock options or awards may be granted pursuant to the Plans is 5,000,000 each, adjusted as provided in Section 11 of the Plan. The Plans expire on December 1, 2014 and December 1, 2015, respectively.

In conjunction with the 2012 Plan, the Company recognized compensation expense for the three months ended March 31, 2014 and 2013 of $411,664 and $518,744  using the Black-Scholes valuation model.  In conjunction with the 2012  Plan, as of March 31, 2014, there was $2,841,378 of unrecognized expense that will be recognized over 1.75 years, 4,050,000 options were outstanding and 1,350,000 were exercisable.

In conjunction with the 2013 Plan, the Company issued 100,000 fully vested shares valued at $137,000 based on the closing price on the date of grant during the quarter ended March 31, 2014.  Additionally, options to purchase 100,000 shares of Company’s common stock were issued to employees serving as  members of the Board of Directors for attending Board and other committee meetings during 2013.  Such options were valued at $103,720 using the Black-Scholes valuation model and the following assumptions: (1) a weighted average expected volatility range of 137.3% – 141.2% based on historical volatility; (2) a weighted average interest rate range of 1.34% - 1.56% (3) a weighted average expected life of 5 years and (4) zero dividend yield. The stock price was determined based on the closing price on the respective dates of the grant.  As of March 31, 2014, under the 2013 Plan, 956,665 options were outstanding of which 846,665 options to purchase the Company’s stock were exercisable. There was no unrecognized compensation expense to be recognized over the next year as of March 31, 2014.
 
The Company recognized compensation cost related to the options for the three months ended March 31, 2014 and 2013 was $519,840 and $525,163, respectively. 
 
The total number of options exercisable under the Plans as of March 31, 2014 was 2,196,665 with a weighted average contract life of 3.59 years and a weighted average exercise price of $1.35.  The aggregate intrinsic value of the options outstanding under the Plans as of March 31, 2014 and 2013 based on a closing price of $0.78 and $1.30 was $42,000 and $0 respectively.

The following table accounts for the Company’s Plans option activity through March 31, 2014:

   
Number of
Shares
   
Weighted
Average
 Exercise Price
 
Options outstanding at December 31, 2013
   
4,943,665
   
$
1.43
 
Options granted
   
100,000
   
$
1.19
 
Options exercised
   
--
   
$
--
 
Options canceled/forfeited
   
(37,000
 
$
1.32
 
Options outstanding at March 31, 2014
   
5,006,665
   
$
1.35
 

Options outstanding as of March 31, 2014:
 
 
Range of Exercise Price
   
 
Number Outstanding
   
Weighted
Average
Contractual Life
 (in years)
   
Weighted Average
 Exercise Price
 
$
0.50 - $1.61
     
5,006,665
     
4.06
   
$
1.35
 
                             
Options outstanding as of March 31, 2013:
 
 
Range of Exercise Price
   
 
Number Outstanding
   
Weighted
Average
Contractual Life
 (in years)
   
Weighted Average
 Exercise Price
 
$
1.46 - $1.61
     
4,350,000
     
4.75
   
$
1.49
 


The following table accounts for the Company’s warrant activity for the period of January 1, 2014 through March 31, 2014:

   
Number of
Shares
   
Weighted
Average
 Exercise Price
 
Warrants outstanding at December 31, 2013
   
37,895,137
   
$
1.42
 
Warrants granted
   
--
   
$
--
 
Warrants exercised
   
(959,000
 
$
0.69
 
Warrants canceled/forfeited
   
--
     
--
 
Warrants outstanding at March 31, 2014
   
36,936,137
   
$
1.44
 


The number of warrants exercisable as of March 31, 2014 was 36,919,337 and 15,814,168 were exercisable as of March 31, 2013.

Warrants outstanding as of March 31, 2014:
       
Weighted Average
   
       
Contractual Life
 
Weighted Average
Range of Exercise Price
 
Number Outstanding
 
(in years)
 
Exercise Price
$
0.50 - $30.00
   
36,936,137
   
3.43
 
$
1.44

Warrants exercisable as of March 31, 2014:
       
Weighted Average
 
       
Contractual Life
 
Weighted Average
Range of Exercise Price
 
Number Outstanding
 
(in years)
 
Exercise Price
$
0.50 - $30.00
   
36,919,337
   
3.42
 
$
1.44

Warrants outstanding as of March 31, 2013:
       
Weighted Average
 
       
Contractual Life
 
Weighted Average
Range of Exercise Price
 
Number Outstanding
 
(in years)
 
Exercise Price
$
1.00 - $51.50
   
16,085,968
   
2.11
 
$
3.13

Warrants exercisable as of March 31, 2013:
       
Weighted Average
 
       
Contractual Life
 
Weighted Average
Range of Exercise Price
 
Number Outstanding
 
(in years)
 
Exercise Price
$
1.00 - $51.50
   
15,814,168
   
2.02
 
$
3.16